Impaired induction of the apoptosis-protective protein Bcl-x(L) in activated PBMC from asymptomatic HIV-infected individuals

Journal of Clinical Immunology

Volumn 17, Issue 3, 1997, Pages 234-246

  Blair, Patrick J ^a   Boise, Lawrence H ^b   Perfetto, Stephen P ^c   Levine, Bruce L ^a   Mccrary, Gil ^c   Wagner, Kenneth F ^c   St Louis, Daniel C ^c   Thompson, Craig B ^b   Siegel, Jeffrey N ^a   June, Carl H ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

apoptosis; cell survival genes; costimulatory molecules; HIV AIDS

Indexed keywords

CD4 ANTIGEN; POKEWEED MITOGEN; PROTEIN BCL 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSIS; DISEASE COURSE; ETIOLOGY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; BCL-X PROTEIN; FEMALE; HIV INFECTIONS; HUMANS; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; POKEWEED MITOGENS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 8244225990     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027310612323     Document Type: Article

References (61)

1. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Murkowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126, 1995
2. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn H, Shaw B: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122, 1995
3. Muro-Cacho C, Pantaleo G, Fauci AS: Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 154:5555-5566, 1995
4. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S: Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392-3400, 1993
5. Ucker DS, Ashwell JD, Nickas G: Activation-driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation. J Immunol 143:3461-3469, 1989
6. Jaleco AC, Covas MJ, Victorino R: Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patients. Clin Exp Immunol 98:185-189, 1994
7. Gougeon ML, Laurent CA, Hovanessian AG, Montagnier L: Direct and indirect mechanisms mediating apoptosis during HIV infection: Contribution to in vivo CD4 T cell depletion. Semin Immunol 5:187-194, 1993
8. Gougeon ML, Garcia S, Heeney J, Tschopp R, Lecoeur H, Guetard D, Rame V, Dauguet C, Montagnier L: Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retrovirus 9:553-563, 1993
9. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 175:331-340, 1992
10. Finkel TH, Tudor WG, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1:129-134, 1995
11. Su L, Kaneshima H, Bonyhadi M, Salimi S, Kraft D, Rabin L, McCune JM: HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity 2:25-36, 1995
12. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee A: Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429-431, 1995
13. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp12O. Nature 375:497-500, 1995
14. + blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc Natl Acad Sci USA 92:7312-7316, 1995
15. Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B: The biochemistry of programmed cell death. Faseb J 9:1277-1287, 1995
16. Cohen JJ: Apoptosis. Immunol Today 14:126-130, 1993
17. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306, 1980
18. Razvi ES, Welsh RM: Apoptosis in viral infections. Adv Virus Res 45:1-60, 1995
19. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438-441, 1995
20. Brunner T, Mogil RJ, La FD, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441-444, 1995
21. Ju ST, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stranger BZ, Marshak-Rothstein A: Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448, 1995
22. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Shooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71-77, 1995
23. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 151:621-627, 1993
24. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756, 1989
25. Sato T, Irie S, Kitada S, Reed JC: FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268:411-415, 1995
26. Klas C, Debatin KM, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5:625-630, 1993
27. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA: Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 181:2029-2036, 1995
28. Gehri R, Sinuhe H, Steuerwald M, Nuesch R, Erb P: The Fas receptor in HIV infection: Expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS 10:9-16, 1996
29. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-fas-mediated cell death in peripheral blood lymphocytes, monocytes and neutrophils. Adv Virus Res 84:1202-1208, 1994
30. Yoshino T, Kondo E, Cao L, Takahashi K, Hayashi K, Nomura S, Akagi T: Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 83:1856-1861, 1994
31. Fang W, Rivard JJ, Ganser JA, Le BT, Nath KA, Mueller DL, Behrens TW: Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J Immunol 155:66-75, 1995
32. Cuende E, Ales-Martinez JE, Ding L, Gonzalez-Garcia M, Martinez F, Nunez G: Programmed cell death by bcl-2-dependent and independent mechanisms in B lymphoma cells. EMBO J 12:1555-1560, 1993
33. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610, 1990
34. Yin XM, Oltval ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required tor inhibition of apoptosis and heterodimerization with Bax. Nature 369:321-323, 1994
35. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240, 1993
36. Boise LH, Gonzalez GM, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608, 1993
37. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886, 1992
38. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Lo DH: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506-1510, 1995
39. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, Thompson CB: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3:87-98, 1995
40. Wang Z, Karras JG, Howard RG, Rothstein TL: Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. J Immunol 155:3722-3725, 1995
41. Grillot DAG, Merino R, Nunez G: bcl-xL displays a restricted expression during thymic development and inhibits multiple forms of apoptosis but not clonal deletion. J Exp Med 182:1973-1983, 1995
42. Grillot DAG, Merino R, Pena JC, Fanslow WC, Finkelman FD, Thompson CB, Nunez G: bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med 183:381-391, 1996
43. + T lymphocytes during HIV infection. J Immunol 156:2282-2293, 1996
44. Adachi Y, Oyaizu N, Than S, McCloskey T, Pahwa S: IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection. J Immunol 157:4184-4193, 1996
45. Redfield RR, Wright DC, Tramont ET: The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Med 314: 131-132, 1986
46. Weng N-P, Levine B, June CH, Hodes RJ: Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 92:11091-11094, 1995
47. Schimenti KJ, Jacobberger JW: Fixation of mammalian cells for flow cytometric evaluation of DNA content and nuclear immunofluorescence. Cytometry 13:48-59, 1992
48. McCloskey TW, Oyaizu N, Coronesi M, Pahwa S: Use of flow cytometric assay to quantitate apoptosis in human lymphocytes. Clin Immunol Immunopathol 71:14-18, 1994
49. Gottschalk AR, Boise LH, Thompson CB, Quintans J: Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc Natl Acad Sci USA 91:7350-7354, 1994
50. Gorczcan W, Gong J, Darzynkiewicz Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translational assay. Cancer Res 53:1945-1948, 1993
51. Levine BL, Mosca JD, Riley JL, Carroll RG, Vahey MT, Jagodzinski L, Wagner KF, Mayers DL, Burke DS, Weislow OS, St. Louis DC, June CH: Antiviral effect from CD28 costimulatory receptor mediates ex vivo CD4 T cell expansion from patients with HIV-1 infection. Science 272:1939-1942, 1996
52. Radvanyi LG, Shi Y, Vaziri H, Sharma A, Dhala R, Mills GB, Miller RG: CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J Immunol 156:1788-1798, 1996
53. Broome HE, Dargan CM, Krajewski S, Reed JC: Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J Immunol 155:2311-2317, 1995
54. Ohta K, Kazuyuki I, Kasahara Y, Taniguchi N, Krajewski S, Reed JC, Miyawaki T: Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-x and Mcl-1 in human peripheral blood and lymphoid tissues. Int Immunol 7:1817-1825, 1995
55. Testi R, D'Ambrosio R, De Maria R, Santoni A: The CD69 receptor: A multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 15:475-483, 1994
56. Noel PJ, Boise LH, Green JM, Thompson GB: CD28 costimulation prevents cell death during primary T cell activation. J Immunol 157:636-642, 1996
57. Abbas AK: Die and let live: eliminating dangerous lymphocytes. Cell 84:655-657, 1996
58. Kehry MR: CD40-mediated signaling in B cells balancing cell survival, growth and death. J Immunol 156:2345-2348, 1996
59. S) gene expression. Eur J Immunol 26:294-299, 1996
60. Sperling AI, Auger JA, Ehst BD, Rulifson IC, Thompson CB, Bluestone JA: CD28/B7 interactions deliver a unique signal to naive T cells that regulate cell survival but not early proliferation. J Immunol 157:3909-3917, 1996
61. Hickey T, Blair PJ, Perfetto S, Smoot D, Wagner K, St. Louise DC, Mayers D, Siegel JN, June CH: Intact antigen receptor-mediated calcium signals in patients with early stage HIV-1 infection. J Immunol 156:4012-4017, 1996